Can you provide the upcoming earnings date for PORTAGE BIOTECH INC?
PORTAGE BIOTECH INC (PRTG) will report earnings on 2025-11-24.
PORTAGE BIOTECH INC (PRTG) Forecast, Price Target & Analyst Ratings
NASDAQ:PRTG • VGG7185A1369
Current stock price
6.81 USD
-0.15 (-2.16%)
At close:
7.4101 USD
+0.6 (+8.81%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PORTAGE BIOTECH INC (PRTG).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $6.81 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
PRTG was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PRTG.
In the previous month the buy percentage consensus was at a similar level.
PRTG was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-01-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-01 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2022-12-01 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-30 | Oppenheimer | Maintains | Outperform |
| 2022-09-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-07 | HC Wainwright & Co. | Initiate | Buy |
| 2021-09-21 | Oppenheimer | Initiate | Outperform |
| 2021-09-02 | B. Riley Securities | Initiate | Buy |
| 2021-08-19 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 24, 2025
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 2,376.00% | N/A 247.98% | ||||||||||||
| EBITDA YoY % growth | -4.32M | -9.19M -112.73% | N/A | N/A | N/A | N/A | N/A | N/A | -16.57M | -18.199M -9.83% | -7.383M 59.43% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.32M | -9.19M -112.73% | -35.49M -286.18% | -2.24M 93.69% | -2.76M -23.21% | -5.98M -116.67% | -12.44M -108.03% | -15.59M -25.32% | -16.57M -6.29% | -18.253M -10.16% | -7.418M 59.36% | N/A -153.28% | N/A -166.02% | N/A -22.45% | N/A 71.67% | N/A 782.35% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -25.80 | -129.80 -403.10% | N/A 99.49% | N/A 20.00% | N/A | N/A -184.62% | N/A 27.03% | N/A 316.67% | N/A 111.11% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-27.59%
EPS Next 5 Year
62.98%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PORTAGE BIOTECH INC / PRTG Forecast FAQ
How many analysts cover PORTAGE BIOTECH INC (PRTG) stock?
The number of analysts covering PORTAGE BIOTECH INC (PRTG) is 6.